Min Jiang

This inventor holds 11 USPTO granted patents and 4 published patent applications and 9 EPO patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 2016-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Min Jiang. Retrieved from https://idiyas.com/inventor/min-jiang-rkaxmj4p

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 4)

% Patents Active = 90.9

EPO Patents = 9 (Patent Applications = 15)

Average Co-Inventor Count = 5.3

ph-index = 4

Forward Citations = 54(Granted Patents)

Company Filing History:

11 out of 5,026

Hoffmann-La Roche Inc.

patents

Years Active: 2016-2023

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11708344 - Flavone derivatives for the treatment and prophylaxis of hepatitis B virus disease (2023-07-25),

2. 11447489 - Dihydropyrimidinylthiazole for the treatment and prophylaxis of hepatitis B virus infection (2022-09-20),

3. 11225482 - Dihydropyrrolopyrimidines for the treatment and prophylaxis of hepatitis B virus infection (2022-01-18),

4. 11104674 - Tetrahydropyridopyrimidines for the treatment of HBV infection (2021-08-31),

5. 10093671 - 2-oxo-6,7-dihydrobenzo[a]quinolizine-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis B virus infection (2018-10-09),

6. 10053461 - Tetracyclic 4-oxo-pyridine-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis B virus infection (2018-08-21),

7. 9949966 - Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection (2018-04-24),

8. 9845322 - Tetrahydropyridopyrimidines and tetrahydropyridopyridines for the treatment and prophylaxis of hepatitis B virus infection (2017-12-19),

9. 9637485 - 6,7-dihydrobenzo[a]quinolizin-2-one derivatives for the treatment and prophylaxis of hepatitis B virus infection (2017-05-02),

10. 9458153 - Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection (2016-10-04),

11. 9458106 - Phenyl-pyridine/pyrazine amides for the treatment of cancer (2016-10-04),

Title: Min Jiang: Innovator in Hepatitis B Treatment

Introduction

Min Jiang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medicine, particularly in the treatment of hepatitis B virus disease. With a total of 11 patents to his name, Jiang's work has the potential to impact many lives.

Latest Patents

Among his latest patents are two notable inventions. The first is focused on flavone derivatives for the treatment and prophylaxis of hepatitis B virus disease. This invention provides novel compounds with a specific general formula, along with compositions and methods for their use. The second patent involves dihydropyrimidinylthiazole for the treatment and prophylaxis of hepatitis B virus infection. Similar to the first, this invention also presents novel compounds with a defined general formula, including compositions and methods for application.

Career Highlights

Min Jiang has worked with reputable companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has contributed to his expertise and innovative capabilities in developing treatments for viral infections.

Collaborations

Throughout his career, Jiang has collaborated with notable colleagues, including Song Yang and Xingchun Han. These partnerships have likely enhanced his research and development efforts in the field of hepatitis B treatment.

Conclusion

Min Jiang's contributions to the medical field, particularly in the treatment of hepatitis B, showcase his innovative spirit and dedication to improving health outcomes. His patents and collaborations reflect a commitment to advancing medical science and providing solutions for viral infections.

Profile summary based on public USPTO records.